Pfizer Retained Earnings (Accumulated Deficit) 2012-2026 | PFE

Pfizer retained earnings (accumulated deficit) for the quarter ending March 31, 2026 were $121.150B, a 0.08% increase year-over-year.

  • Pfizer retained earnings (accumulated deficit) for 2024 were $116.725B, a 1.38% decline from 2023.
  • Pfizer retained earnings (accumulated deficit) for 2023 were $118.353B, a 5.81% decline from 2022.
  • Pfizer retained earnings (accumulated deficit) for 2022 were $125.656B, a 21.53% increase from 2021.

Pfizer Retained Earnings (Accumulated Deficit) 2012-2026 | PFE

  • Pfizer retained earnings (accumulated deficit) for 2024 were $116.725B, a 1.38% decline from 2023.
  • Pfizer retained earnings (accumulated deficit) for 2023 were $118.353B, a 5.81% decline from 2022.
  • Pfizer retained earnings (accumulated deficit) for 2022 were $125.656B, a 21.53% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B